Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients
Obestatin, a proposed anorexigenic gut hormone, has been shown to have a number of beneficial cardiotropic effects in experimental studies. We hypothesized that obestatin alteration in hemodialysis patients may link to clinical outcomes. This cross-sectional study with prospective followup for almos...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786512/ |
id |
pubmed-3786512 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-37865122013-10-07 Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients Beberashvili, Ilia Sinuani, Inna Azar, Ada Kadoshi, Hadas Shapiro, Gregory Feldman, Leonid Sandbank, Judith Averbukh, Zhan Clinical Study Obestatin, a proposed anorexigenic gut hormone, has been shown to have a number of beneficial cardiotropic effects in experimental studies. We hypothesized that obestatin alteration in hemodialysis patients may link to clinical outcomes. This cross-sectional study with prospective followup for almost 4 years was performed on 94 prevalent hemodialysis patients. Obestatin, leptin, proinflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6, and various nutritional markers were measured. Patients with low obestatin levels, defined as a level less than median, had a worse all-cause mortality and cardiovascular mortality. The crude all-cause (HR 2.23, 95% CI 1.17 to 4.24) and cardiovascular mortality hazard ratios (HR 4.03, 95% CI 1.27 to 12.76) in these patients continued to be significant after adjustment for various confounders for all-cause mortality. Across the four obestatin-TNF-α categories, the group with low obestatin and high TNF-α (above median level) exhibited a worse outcome in both all-cause mortality and cardiovascular mortality. Clinical characteristics of patients in low obestatin high TNF-α group did not differ from other obestatin-TNF-α categorized groups. In summary, low serum obestatin concentration is an independent predictor of mortality in prevalent hemodialysis patients. Novel interactions were observed between obestatin and TNF-α, which were associated with mortality risk, especially those due to cardiovascular causes. Hindawi Publishing Corporation 2013 2013-09-12 /pmc/articles/PMC3786512/ /pubmed/24102059 http://dx.doi.org/10.1155/2013/796586 Text en Copyright © 2013 Ilia Beberashvili et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Beberashvili, Ilia Sinuani, Inna Azar, Ada Kadoshi, Hadas Shapiro, Gregory Feldman, Leonid Sandbank, Judith Averbukh, Zhan |
spellingShingle |
Beberashvili, Ilia Sinuani, Inna Azar, Ada Kadoshi, Hadas Shapiro, Gregory Feldman, Leonid Sandbank, Judith Averbukh, Zhan Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
author_facet |
Beberashvili, Ilia Sinuani, Inna Azar, Ada Kadoshi, Hadas Shapiro, Gregory Feldman, Leonid Sandbank, Judith Averbukh, Zhan |
author_sort |
Beberashvili, Ilia |
title |
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
title_short |
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
title_full |
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
title_fullStr |
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
title_full_unstemmed |
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients |
title_sort |
low serum concentration of obestatin as a predictor of mortality in maintenance hemodialysis patients |
description |
Obestatin, a proposed anorexigenic gut hormone, has been shown to have a number of beneficial cardiotropic effects in experimental studies. We hypothesized that obestatin alteration in hemodialysis patients may link to clinical outcomes. This cross-sectional study with prospective followup for almost 4 years was performed on 94 prevalent hemodialysis patients. Obestatin, leptin, proinflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6, and various nutritional markers were measured. Patients with low obestatin levels, defined as a level less than median, had a worse all-cause mortality and cardiovascular mortality. The crude all-cause (HR 2.23, 95% CI 1.17 to 4.24) and cardiovascular mortality hazard ratios (HR 4.03, 95% CI 1.27 to 12.76) in these patients continued to be significant after adjustment for various confounders for all-cause mortality. Across the four obestatin-TNF-α categories, the group with low obestatin and high TNF-α (above median level) exhibited a worse outcome in both all-cause mortality and cardiovascular mortality. Clinical characteristics of patients in low obestatin high TNF-α group did not differ from other obestatin-TNF-α categorized groups. In summary, low serum obestatin concentration is an independent predictor of mortality in prevalent hemodialysis patients. Novel interactions were observed between obestatin and TNF-α, which were associated with mortality risk, especially those due to cardiovascular causes. |
publisher |
Hindawi Publishing Corporation |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786512/ |
_version_ |
1612015107632529408 |